Sign in Subscribe
Universities and colleges

The Prostate-Derived ETS Factor: A Promising Tumor Metastasis Suppressor

Strategic Insights

— 1 min read

Scientists at the University of Colorado have identified the prostate-derived ETS factor (PDEF) as a unique member of the ETS transcription factor family, with a significant role in regulating the expression of prostate-specific antigen and androgen receptor co-regulation. PDEF expression is highly restricted to epithelial cells and has been found in prostate, breast, colon, ovary, gastric, and airway epithelium, with strong preclinical evidence suggesting its negative regulatory role in tumor progression and metastasis. The loss of PDEF expression in late-stage tumors is thought to contribute to tumor aggressiveness, with PDEF-regulated gene targets playing a crucial role in tumor cell invasion and metastasis.

Key Takeaways:

  • PDEF is a unique member of the ETS transcription factor family, with a significant role in regulating prostate-specific antigen and androgen receptor co-regulation.
  • PDEF expression is highly restricted to epithelial cells and has been found in prostate, breast, colon, ovary, gastric, and airway epithelium.
  • Strong preclinical evidence suggests PDEF's negative regulatory role in tumor progression and metastasis.
  • The loss of PDEF expression is thought to contribute to tumor aggressiveness, with PDEF-regulated gene targets playing a crucial role in tumor cell invasion and metastasis.
  • J.J. Steffan and colleagues have published their study in Cancer Letters, detailing PDEF-regulated gene products and expression profiles in clinical tumor samples.
  • The researchers conclude that PDEF may function as a tumor metastasis suppressor, with implications for cancer gene therapy and tumor progression.
  • PDEF expression is often lost in late-stage, advanced tumors, with significant implications for cancer treatment and prognosis.

Statistics:

  • 109-117 genes are regulated by PDEF, according to the study published in Cancer Letters.
  • PDEF expression has been found in prostate, breast, colon, ovary, gastric, and airway epithelium.
  • The loss of PDEF expression is thought to contribute to tumor aggressiveness, with a significant impact on cancer prognosis and treatment.
  • 1 decade of research has led to significant advances in understanding PDEF's role in tumor progression and metastasis.

Sources:

  • Steffan, J.J., et al. "Prostate derived ETS factor (PDEF): A putative tumor metastasis suppressor." Cancer Letters, 2011;310(1):109-117.
  • Cancer Gene Therapy, Aurora, CO, 2011.

Read more